Moelis & Company (MC) Earnings Call Transcript & Summary
November 5, 2026
Earnings Call Speaker Segments
Matthew Tsukroff
executiveGood afternoon, and thanks for being with us on the call covering Moelis & Company's financial results for the third quarter of 2026. Joining us by phone are Navid Mahmoodzadegan, our CEO and Co-Founder, along with Chris Callesano, our Chief Financial Officer. Ahead of getting started, please be aware that what we say today may include forward-looking statements, and those carry a range of risks and uncertainties, among them the ones described periodically within the Risk Factors section of the filings Moelis & Company makes with the SEC. What actually happens could end up materially different from what is presently expected. The firm takes on no duty to revise any forward-looking statements. In our remarks today, we refer to certain adjusted financial measures. It is our view that these measures, when shown alongside comparable GAAP measures, help investors in comparing our results over multiple periods and in gaining a clearer picture of our operating results. Reconciliations of these adjusted financial measures to the pertinent GAAP financial information, plus the other information Reg G requires, appear in the firm's earnings release, available on our Investor Relations website at investors.moelis.com. I'll now hand the call over to Navid.
Navid Mahmoodzadegan
executiveThanks, Matt. It's a pleasure to be here with all of you. This is definitely an unusual afternoon for an earnings call, but I'm happy to be joining you. We had yet another busy quarter advising clients and are carrying forward the momentum in our business; third quarter revenues came in at $426 million, a 13% rise over the prior-year period. That quarterly revenue gain was driven by considerable growth in our M&A business along with strong results in capital structure advisory. Across the first 9 months of 2026, revenues reached $1.15 billion, up 10% year-over-year, marking a record first 9 months for us. For both the quarter and the first nine months, the average fee we earned on each completed transaction set a record as well, since we keep guiding clients through bigger and more intricate assignments. Among these are several noteworthy deals announced after our previous earnings call. Our top-ranked Special Committee advisory practice has been quite busy, having lately advised on multiple assignments, among them Meta's creation of a new class of common stock, Penske Automotive's $16 billion take-private, and Surgery Partners' $5.7 billion sale to HealthSpan Partners. In addition, we advised QIAGEN on its EUR 10.8 billion sale to EQT, and Marathon Petroleum on its $4.2 billion divestment of certain assets to CVR Energy. On the Capital Markets side, we served as advisors to Sequence Holdings and DFO Management on $3.7 billion in financing tied to the acquisition of The Baldwin Group. Over in Capital Structure Advisory, our team advised Medical Properties Trust regarding its liability management transactions totaling $2.4 billion. Then in PCA, BlackRock received our advice on capitalizing a private credit continuation vehicle. Turning to the market — our outlook for transaction activity stays constructive, since the fundamentals underpinning M&A are still very much in place. Companies understand that standing still isn't a viable option. Demand for M&A keeps being driven by the need to build scale, strengthen market positioning, and enhance growth. We’re keeping an eye on things like increased market swings, geopolitical friction, elevated rates, and ambiguity around funding for AI infrastructure—but client activity is still robust. As of right now, new business origination and the pipeline we’ve announced are both roughly 20% higher year-over-year, and our overall pipeline sits at an all-time peak. Moving on to our product areas: our M&A business keeps delivering excellent results. M&A revenue for the third quarter rose 40% year-over-year, powered by substantial gains in strategic M&A. The talent we’ve brought in, the capabilities we’ve broadened, and our platform’s ongoing maturation are all leading to more assignments where we advise major corporate clients on important transactions. On top of that, our sponsor M&A practice has had a strong year as well, even though activity across the sponsor market overall has lagged what people expected. In particular, we advised on roughly 30% more sponsor M&A deals in the first nine months of this year, which shows how strong our long-standing relationships are and how we keep working with this key client base. Our capital structure advisory business has just recorded one of its strongest quarters to date, and revenue growth for the year so far is keeping pace with the broader firm. The themes in the market today line up with what we described last quarter. Liability management solutions continue to account for a large portion of activity, and since lenders have become more selective, refinancing has grown more difficult for lower-quality credits. Going forward, with lenders showing less appetite to roll upcoming maturities, we anticipate traditional restructuring will pick up over time. On top of that, the recent uptick in interest rates, plus continuing dislocation across a number of industries, could widen the opportunity set further for our CSA business. Turning to capital markets, third quarter revenues came in softer after a record first half, mainly reflecting greater market volatility and the timing of transactions. Even so, our capital markets pipeline keeps expanding, with both transaction count and related fees at record levels. Client demand underneath is strong in public and private markets alike, as unprecedented capex tied to AI and digital infrastructure and other high-growth sectors keeps fueling issuance activity. We have confidence in this business's prospects, although the timing of deal completions remains dependent on market circumstances. Finally, private capital advisory. Strong expansion continues in the secondaries market, fueled by significant pressure to raise DPI throughout private market portfolios and growing investor demand for high-quality, established assets. In this market our PCA team is extremely active, securing new mandates and assembling a substantial pipeline. We continue to make considerable progress in expanding our PCA capabilities. Every one of the 7 managing directors focused on GP-led secondaries is now part of our platform, and the teams for LP-led secondaries and promoted co-investment that we added not long ago have gotten off to a solid start; also, since the previous earnings call, we have recruited 3 managing directors whose focus is primary fundraising, and they will be joining us in the months ahead. Given the team we are putting together along with our strong sponsor relationships, we feel we are making good progress toward creating a best-in-class PCA business that serves clients throughout the private capital ecosystem. That brings me to how we invest in talent. Attracting and advancing top talent remains a central strategic priority. So far this year, we have added 24 managing directors, which makes this the busiest recruiting year we have ever had. Thirteen managing directors are now on board, and seven of them arrived after our previous earnings call. The other eleven are expected to come in during the remainder of 2026 and on into 2027, adding depth in TMT, financial institutions and industrials — all big fee pools with appealing long-term growth prospects — and also in primary fundraising inside PCA, as I noted earlier. We remain active in the recruiting market and continue talking with outstanding bankers capable of being difference bankers on our platform. Before I finish, I want to call out the substantial headway we're making in embedding AI throughout our business. I'm especially enthusiastic about how our teams are working together to build new use cases and bring these tools into workflows that can be rolled out across the entire firm. Although we're only at the beginning, we're convinced AI will meaningfully boost productivity, letting us come up with more ideas, offer stronger advice, and in the end open up additional transaction opportunities for our clients. To wrap up, our franchise is delivering at a very strong level even with a complicated market environment. Our pipeline is robust and diversified, and the finest talent is serving more clients now than at any other time in our history. Possessing a wide range of capabilities lets us give our clients the best guidance through stretches of market volatility. We stay committed to providing outstanding advice, investing in our business's long-term growth, and generating enduring value for our shareholders. With that, I'll hand the call over to Chris so he can walk through our financial results in greater detail.
Christopher Callesano
executiveThank you, Navid, and good afternoon to all of you. As Navid mentioned, third quarter revenues came in at $426 million, which is a 13% increase over the same period last year, with the growth mainly driven by M&A and capital structure advisory, partly offset by weaker capital markets. For the first 9 months of the year, revenues reached a record $1.15 billion, rising 10% year-over-year. That year-to-date revenue increase was largely due to M&A, capital structure advisory, and a growing contribution from TCA. Across the first 9 months of the year, our business mix was roughly 70% M&A and 30% non-M&A. Now on to expenses. Our adjusted compensation ratio came in at 65.8% for both the third quarter and the first 9 months of 2026, versus 66.2% and 68% in the prior year period. As we've said before, we anticipate bringing our compensation ratio down over time, with how much improvement we achieve depending on revenues and a competitive market for talent. Adjusted noncompensation expenses totaled $61.3 million in the third quarter, which works out to a 14.4% noncompensation expense ratio; for the first 9 months of the year, adjusted noncompensation expenses were $195 million, up 19% year-over-year, for a noncompensation expense ratio of 16.9%. What's mainly driving the expense growth in both current year periods is higher occupancy costs tied to our New York and London offices, greater technology and data expenses, including investments in AI, and increased business and client activity, including more deal-related travel and client conferences; for the full year, we expect noncomp expenses to grow approximately 19% over last year. Our adjusted pretax margin was 21.4% for the third quarter and 18.6% for the first 9 months of 2026, compared with 22.2% and 18.2%, respectively, in the prior year period. Our effective tax rate for the quarter was 29%, about in line with the third quarter of 2025. Moving to capital allocation. The Board declared a regular quarterly dividend of $0.65 per share, consistent with the prior period; during the third quarter, we repurchased 278,000 shares on the open market net settlement at a total cost of roughly $19 million. Over the first 9 months of the year, we've repurchased 2.6 million shares at a total cost of approximately $160 million. Counting the dividend declared today, we will have returned about $318 million of capital to shareholders with respect to the first 9 months of 2026. And lastly, we closed the quarter with a strong cash position of $659 million and no debt. With that, we can open the line for questions.
Devin Ryan
analystI want to ask about the pipeline and how it ties into converting revenue. Thanks for the detail on new business origination and the 20% year-over-year increase in announced pipeline. I think you mentioned that total pipeline is at a record. But you're also pursuing some bigger deals, and as we saw today, market conditions are fairly complicated. Could you discuss the pace of conversion and how it has been changing over just the last few months? And then, assuming we're past the midterm now, with certain verticals needing to be reconsidered and obvious ripples surrounding that, do events like these significantly extend transaction timing? Or do you figure it'll actually stay limited to certain sectors and particular deals? I'm just wondering — since you've lived through these sorts of turbulent stretches before, I'd like to hear your view on what's likely to play out.
Navid Mahmoodzadegan
executiveAbsolutely. Thank you, Devin. I'm glad you raised that. And I realize each company tends to view its pipeline in its own way. I simply want to be sure it's clear how we approach ours. Whenever fresh business reaches our firm and we're already engaged on an assignment for a transaction, then clearly, since we're devoting effort to it, we believe there's a sensible likelihood it will close; that's the sort of item that goes into our pipeline; and to be clear — any given deal either closes, falls apart, or remains ongoing, and that is precisely what moves the overall pipeline. So within the broader pipeline, when we announce a deal — when we announce all the deals that are happening — those generally convert at a very high rate. Typically the only factor that affects that is regulatory; if a regulatory issue arises, that changes things. So announced pipeline converts at a very high level. And then within our overall pipeline, obviously there are various conversion metrics we track, and things such as market volatility affect some of those businesses differently than others. A CSA mandate, for example, usually converts at a very high rate, because much of that business is retainer-based — something will happen. You don't always know when. On one end of the spectrum, a CSA mandate or a PCA mandate usually shows extremely high conversion on deals in the pipeline. Capital markets might sit closer to the opposite end, since it depends on the market and market volatility could affect it. Then M&A lands somewhere in between, depending on whether it's strategic M&A or sponsor M&A, right? But as I mentioned, every key metric and every key KPI we track—overall activity, things entering our pipeline—and certainly announcements, are at very strong levels. We're clearly processing the events of the last 48 hours. It's been an interesting last 48 hours, and we're still getting our head around that. That said, I really believe the key theme here is having a wide-ranging set of capabilities so we can pivot as market conditions change, and being able to advise our clients — making sure we offer the right guidance and the right capabilities to help them navigate stretches of market volatility — that's truly essential, and we're very glad we're in a position where we can do that.
Devin Ryan
analystUnderstood. Thanks for that. I wanted to circle back briefly on the private capital advisory platform and the scaling you're seeing in it; it sounds like that business keeps contributing at a growing level. To get a bit more specific, could you speak to how it's becoming more impactful to the firm on its own, and share anything else about that contribution. Also, is it generating more opportunities on the M&A side with sponsors? And does it play a part in some of these larger fee deals? I'm just curious, given the momentum as you've brought on numerous bankers since 2023, about the contribution there and the network effect across the firm.
Navid Mahmoodzadegan
executiveSure. So, the PTA build is still at a fairly early stage. Matt Wesley, who heads that business for us, came on board earlier last year, so he's now been on the platform for a little over a year. He's been busy assembling the team. As I said in the prepared remarks, the GP-led secondaries team is the furthest along right now, with seven MDs working on active mandates. Revenue already reflects recognition of deal closings and some revenue. It isn't material this year or this quarter. But as we look toward next year, there's definitely a meaningful pipeline forming, and we feel great about that business. The two other areas where we've already got personnel on the ground are the promoted co-investment operation and the LP secondary operation, and both are quite early-stage. Those folks are therefore only now ramping up, though the start has been promising thus far. Then, as I noted, the primary fundraising group—typically a business characterized by a rather longer lead time—those teams really aren't in place yet. The senior members of those teams won't be joining until next year. And after that, some period will be needed before primary fundraising can secure mandates, bring in capital, and generate meaningful revenue. So my feeling about the team is excellent. In my view, the set of hires we've made is exactly the right one. The potential here is every bit as strong as I originally expected, and we're very much on schedule. I think your point is spot on. For instance, we've already had assignments where we came in with both the M&A group and the PCA group. Nobody was quite certain — the sponsor itself hadn't decided — whether they'd pursue an M&A deal or set up a continuation vehicle. Without that PCA capability, there's a real possibility those assignments wouldn't have come to us; and while some of them remain PCA, others are shifting over to M&A. Having both capabilities matters, too, because sometimes the benefit never appears in PCA at all—it surfaces in M&A instead—yet without the PCA capability you would have suffered an opportunity loss. We are definitely seeing that happen right now.
James Yaro
analystI was hoping you could go into a bit more detail about how the restructuring cadence looks from here. When you consider the outlook going forward, does a handoff occur between liability management and traditional restructuring? Or would that be more of a seamless growth trajectory, potentially? And then perhaps just over what potential that handoff, or shift from one type of mandate to another, could occur?
Navid Mahmoodzadegan
executiveSo great question, James; so all of that, both liability management and traditional restructuring, happens and is processed through our CSA capability. It's not a handoff from one part of the firm to another. Another aspect that sets our go-to-market approach apart is the presence of sector bankers—and, for sponsor deals, occasionally sponsor coverage bankers—within those teams. That gives us a highly collaborative and tightly integrated model, which stands out sharply in the CSA space. It's fairly distinctive, and I believe it's part of what has let us build a leading CSA franchise. Regardless of whether the deal takes the form of a liability management transaction or ultimately becomes a restructuring, the CSA team professionals handling it are identical—they possess deep expertise across every variation of CSA deals. Consequently, the deal teams remain unchanged. Moreover, since sector teams are typically involved as well, should the focus shift toward M&A—whether as a component of that transaction, which does happen, or as a follow-on to restructuring, given our collaborative approach—those transitions are extremely smooth within our firm.
James Yaro
analystAll right, that's clear. Perhaps one additional question regarding the restructuring area. How would you view the consequences of possible stress affecting certain portions of the AI financing complex? And in what ways might that affect your restructuring business—or rather, your CSA business, I mean?
Navid Mahmoodzadegan
executiveWell, look, whenever stress exists somewhere in the system, whenever disruption is occurring in any sector—particularly one where a great deal of capital formation has taken place—obviously our CSA team is strongly placed to capitalize on it. And indeed, AI infrastructure has been an arena of enormous capital formation. For the past few years, it has truly been the leading theme across the capital markets. And should some of these situations tip over, or should a wide-ranging group of them tip over into greater liability management, restructuring, workout, and so forth, then certainly—again, given the combination of the fact that we possess a very robust data center emerging telecom team that has worked on and is working on numerous of these financings and M&A transactions, plus a robust CSA team—we would certainly be strongly placed to capitalize on it.
Alex Bond
analystI'd like to dig a bit deeper into the sponsor side and what the outlook looks like there. You said the count of sponsor transactions we've advised on year-to-date has risen 30%. Could you perhaps talk about where that strength is coming from — whether it's contributions from particular sector teams or something else? And also, how have interest rate moves affected activity levels more recently, plus your outlook for sponsor volumes growing from here?
Navid Mahmoodzadegan
executiveWell, I think the figure I referenced wasn't purely M&A. It was sponsor transactions broadly; and so I do believe that, once again, the broader-based character of our capabilities has genuinely helped us capture a larger share of sponsor wallet. That's been a key component, again, of having capital markets and having PCA to pair with CSA and restructuring and M&A so we're truly front and center with sponsors as a solution provider; in this particular year, obviously, sell-side is always a major piece of our franchise, but we do from time to time in this year, we've had a fair amount of buy-side work with sponsors. So something I'm really proud of is that the more and better sector teams we have focused across more areas, the more capabilities we have for advising sponsors, the more wallet share we're going to take. And we're definitely seeing that in a year like this where generally sponsor activity is somewhat sluggish, somewhat muted. It's getting better, but it's not where everybody wants it to be. And yet our share of sponsor wallet, we believe, is improving.
Alex Bond
analystUnderstood. That's clear; and as a follow-up, I'd like to ask about comp expectations for 4Q. Given where year-to-date revenue numbers stand, could you speak to how confident you are that we can drive additional leverage in the fourth quarter, and how should we be thinking about comp more generally as we start to think about '27 as well? Any additional color would be great.
Navid Mahmoodzadegan
executiveLook, I think we began the year expecting that we would get some comp leverage. We haven't adjusted the comp ratio, as you can see for the first 9 months of the year, but our expectation remains that by the time the year finishes up, we will be able to exhibit some comp leverage and a reduction in the comp ratio; so that continues to be our expectation.
Steven Chubak
analystTo begin, I’d like to ask about the outlook for noncomps after this year. You mentioned a number of the drivers behind the growth in noncomps. I’m trying to understand how we ought to think about how long the AI investment cycle will last, given the substantial investments you and several of your peers are putting into the technology side, and whether you could lower the cost curve beyond ’26 or if that elevated pace of investment will need to continue just because of how long this AI cycle runs?
Navid Mahmoodzadegan
executiveYes. Thanks for the question; it will be hard to lead off by projecting 2027 at this point. We are in the middle of our bottoms-up budgeting process, right? So we take a close look at what’s required and what savings opportunities exist. We keep emphasizing better cost savings and pretax margins. I would say, if you focus specifically on technology, that’s an item I can see continuing to grow in 2027, whereas, for example, real estate is another line item that would not grow as much. But right now, I mean, I think we are not going to give any concrete guidance for 2027, apart from saying that we’ll likely be able to share more at our next earnings call.
Christopher Callesano
executiveAllow me to add one thing there. Steven, you're correct that technology spending has gone up, driven by AI and other factors. As I said, we—like everyone else—are bringing AI in, testing it out, and we're enthusiastic about the potential benefits for our company. Those expenses are going to keep rising. That said, we are intensely focused on ensuring we use these tools as efficiently as possible. As we shift toward token-based consumption, which is probably coming soon for us and for our competitors, it will be extremely important to stay sharply focused on efficiency and to apply the right tools to the right task. Second, eventually we will need to capture efficiencies across the organization and drive them through our organizational structure—and above all when it comes to productivity. So we genuinely believe the AI spending will deliver a positive return over time. And we are intensely focused on ensuring we can monitor that and prove it once this adoption phase is behind us.
Steven Chubak
analystNo, that's genuinely useful context. And as a follow-up, I wanted to ask about the 162M tax provision that is anticipated to take effect starting next year. From what I can see, for you and certain peers of yours, it might have a fairly substantial effect on the tax rate going forward. I was hoping you might address at least some of your early conclusions drawn from the work completed so far.
Navid Mahmoodzadegan
executiveYes. Appreciate that. Yes, at present we are assessing the impact. As you can imagine, there are numerous variables that will influence the rates as we move toward year-end. Still, to begin with, we can envision adding a few points to our tax rate. We'll be able to share further details on our next earnings call and then, naturally, the first earnings call once it is finalized.
Steven Chubak
analystAre there any guardrails around that?
Navid Mahmoodzadegan
executiveAt this point, I believe there are too many variables still open, so I think we'll stay with a few points — probably give or take a point or 2 on either side.
Gabriel Angelini
analystClearly, things were pretty robust this quarter, and revenue growth, I'd say, actually picked up modestly on a year-over-year basis versus the second quarter, which was good to see. And I do appreciate that the pipeline is up 20% year-over-year, but my sense is that it's somewhat below the 80% mark that you mentioned last quarter. So with that in mind, could you speak to where you believe we sit in the current M&A cycle? And would it be fair to say we're past the early innings at this point?
Navid Mahmoodzadegan
executiveYeah. Look, I'm not certain those 2 data points bear any relevance to the notion of where we stand in the M&A cycle. So look, M&A cycles are extremely, extremely difficult to forecast. Everything we observe looking into the foreseeable future is really strong demand for M&A, coming both from strategics and from financial sponsors. Now in the prepared remarks, we did discuss some of the headwinds that we must navigate in order for the M&A pipeline to convert into M&A completions; and certainly, we take none of those things for granted. Whether that's geopolitical risk or some of the volatility you're seeing in the marketplace, there are factors that could affect the pacing of M&A completions; but the underlying fundamentals, the need for scale, the need for growth, the need to deal with technology disruption, the sponsor need to get DPI, all of those things point to a healthy level of M&A demand for a long period of time. Typically, with these cycles, you can only predict in hindsight when an event happens, and that's the end of the cycle; it's very hard to predict those on a go-forward basis.
Gabriel Angelini
analystUnderstood — that helps. Then, just as a quick follow-up: it seems the mix of business might have tilted a bit further toward M&A this quarter compared with the usual roughly 2/3, 1/3 split. So I'm just curious whether greater M&A strength this quarter drove that; and I realize you don't disclose the non-M&A businesses separately, but any color you could give on how they performed relative to each other would be useful.
Navid Mahmoodzadegan
executiveIn a business such as ours, particularly now that our capabilities have expanded, it's simply difficult to read too much into any 1 quarter or 2. As I mentioned earlier, our M&A business is healthy and vibrant, as shown by its continued growth. CSA has had a good year and a very good past quarter. Capital markets had a softer quarter, even though last year was a record year for them and the first 6 months of the year were a record. So when you examine any particular quarter or 2, client activity has vagaries that affect timing, along with things very specific to clients and sometimes things specific to the market, which affect part of the revenue composition in any one period. And I'm not sure I read too much into any quarter or 2.
Nathan Stein
analystMarkets dropped today over AI worries that were pretty widespread; and although that is clearly only a single day and one lone data point, I still wanted to ask: what would a significant deceleration or postponement in AI-related CapEx or data center construction mean for your business and your pipelines?
Navid Mahmoodzadegan
executiveYes. Look, that's a good question. I think, look, we are still digesting what happened over the last 48 hours. I think coming off the blue wave on Tuesday, I think how the market read that yesterday differed greatly from how the market read it today, even though there wasn't much news between yesterday and today, right? So in a sense, if you look at some of the political changes, you could draw a positive picture about how likely it is that the Middle East conflict continues, and about what might come from tariffs being rolled back, inflation perhaps getting under control, and some checks and balances that could be very helpful in supporting M&A activity and financing activity. At the same time, there's definitely more political risk in the system surrounding data center development and that sort of thing, and the market was fixated on that today. And look, again, I keep coming back to this idea of having a broad-based business. Adapting to whatever the market throws at us is crucial. Over the past year or two, a big chunk of the market — definitely the financing and public equity sides — has been shaped by all the money being raised for AI and digital infrastructure, and we've made the most of that. So if things change direction there, certain areas of our business tied to financing and M&A in some of those markets could take a hit, while other areas could stand to gain. One thing I believe has happened across the past 12 to 18 months is that attention and emphasis have concentrated so heavily on the AI trade and the capital formation surrounding it that funding for other growing, vibrant areas has effectively been squeezed out. So much focus and so much money have flowed toward that hot sector that it has become somewhat more difficult to raise funds for businesses whose growth isn't at the same scale, even though those businesses remain quite healthy and very vibrant. One upside, should there be a disruption—even a significant one—in AI infrastructure, is that money might swing back toward conventional enterprises that deserve investment. We'll have to wait and see. We're watching everything closely. It's all unfolding live, but that's a really good question.
Nathan Stein
analystThanks for the extra detail. I’ve got a quick question about the noncomp expense dollars. Back in July, you mentioned noncomp would be in the mid- to high $60 million range for both 3Q and 4Q of this year. It came in below that this quarter, but from the full-year comment, it sounds like 4Q will be near the high end of the range. So I wanted to ask: was there a lumpy cost that was perhaps removed or shifted into 4Q? And over the longer term, is that mid- to high $60 million range a good way to think about noncomp dollars?
Navid Mahmoodzadegan
executiveYes. I’d say Q3 this quarter was a bit lighter because of some seasonality, with lower travel during the summer months. There were also fewer underwriting syndication costs tied to the capital markets business; however, as you can imagine, costs do move from one quarter to the next. So it’s probably best to view noncomp on a full-year basis. And as I said in the prepared remarks, we expect it to grow approximately 19%. So I think we’ve been pretty consistent since the beginning of the year that we thought it would grow in the high teens, and it looks like that’s probably where we’ll land.
Mike Brown
analystI'd like to ask about software M&A trends. And I wanted to check in on how that's shaping up this year. Obviously, it was quite restricted earlier in the year amid a lot of AI uncertainty in the market. Are you beginning to see more activity flow through in that sector? It looks like we've had a couple of larger deals, but I'm wondering whether that's starting to widen out and you're seeing more of that activity enter your pipeline.
Navid Mahmoodzadegan
executiveSure. Yes. Thanks for that, Mike. It's a good question. So, going back to when the apocalypse hit earlier this year, I believe on the call right after that, we talked a little about how the market had painted anything tied to software with one very wide stroke. We felt, at minimum, that this was overdone—that as time went on, real distinctions would emerge across various kinds of software companies. Some would adjust and flourish in the AI era, genuinely leaning into AI to reshape how they operate and becoming extremely dynamic, whereas others would find things difficult, with possible consequences for their business model and for their terminal value. So now that we're several quarters beyond that point, I think what we're witnessing is exactly that. Sure. Looking at the public markets, several of the cohorts — the software companies within that cohort — have seen public market valuations essentially return to prior levels, despite what happened over the past couple of days. On the M&A side, we are clearly observing significant private activity as well as private company M&A in specific areas of the software sector, with cyber being a strong example. So yes, some M&A is taking place in pockets of the software industry. It is not yet broad-based. I still believe a healthy portion of the ecosystem remains uncertain — even though they have not yet seen any business model impact from AI, concerns persist regarding terminal value, terminal multiples, and similar matters. For a portion of those businesses that are highly leveraged, our teams are definitely engaged in conversations and efforts centered on exploring opportunistic liability management for certain of them; that keeps our CSA team occupied with some of those names. So I believe some differentiation is emerging, though we're still in the early stages.
Mike Brown
analystAll right, thank you. I suppose I'd like a brief point of clarity regarding what you mentioned last. At this stage, is the team beginning to observe any of those software restructuring efforts or liability management exercises materialize? If not, how do you see it — what's your best estimate for timing? Would that be more of a '27 event, or something later in the second half of '27? Any perspective you could offer would be useful.
Navid Mahmoodzadegan
executiveA few are showing up, though I'd characterize them as still preliminary liability management work discussions and advice. So my sense is it will take a bit more time before some of those conversations gain traction. Whether most of that lands in '27 or '28 is difficult to predict, but I would point out that beginning in '28 and '29, a considerable volume of debt maturities comes due, and software accounts for a very substantial share of certain of those maturities; so my view is that you'll probably witness a considerable amount of liability management activity across the coming 12 to 18 months.
Navid Mahmoodzadegan
executiveAppreciate everyone giving us their time this afternoon. We’re looking forward to talking with all of you again before long. Enjoy a great evening.
Operator
operatorThis concludes today's call. Thank you for attending. You may now disconnect.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Moelis & Company transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Moelis & Company earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Moelis & Company or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.